FDA Clears Prime Medicine’s IND for First Prime Editing Therapy
Prime Medicine said it has gained FDA clearance for the first human trials of a prime editing therapy as the agency has approved an investigational new drug (IND) application for the company’s first candidate to enter the clinic.